Skip to content
10-Q

Quarterly Report

NUTRALIFE BIOSCIENCES, INC.

0001493152-22-014754

← back to feed
Filed
May 23, 2022 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2022 · May 20, 2022 175.6M sh
Operating Cash Flow Q1 2022 · Mar 31, 2022 −$453.19K
Operating Cash Flow restated Q1 2022 · Mar 31, 2021 −$356.01K
Cash And Equivalents Q1 2022 · Mar 31, 2022 $58.26K
Cash And Equivalents Q1 2022 · Dec 31, 2021 $135.77K
Stockholders Equity Q1 2022 · Mar 31, 2022 −$1.25M
Stockholders Equity Q1 2022 · Dec 31, 2021 −$712.53K
Stockholders Equity Q1 2022 · Mar 31, 2021 $193.64K
Stockholders Equity Q1 2022 · Dec 31, 2020 $301.11K
Current Liabilities Q1 2022 · Mar 31, 2022 $4.26M
Current Liabilities Q1 2022 · Dec 31, 2021 $4.48M
Total Liabilities Q1 2022 · Mar 31, 2022 $6.83M
Total Liabilities Q1 2022 · Dec 31, 2021 $5.56M
Current Assets Q1 2022 · Mar 31, 2022 $445.9K
Current Assets Q1 2022 · Dec 31, 2021 $518.3K
Total Assets Q1 2022 · Mar 31, 2022 $5.59M
Total Assets Q1 2022 · Dec 31, 2021 $4.85M
Eps Basic Q1 2022 · Mar 31, 2022 −$0.01
Eps Basic Q1 2022 · Mar 31, 2021 −$0.02
Net Income Q1 2022 · Mar 31, 2022 −$1.08M
Net Income Q1 2022 · Mar 31, 2021 −$2.5M
Operating Income Q1 2022 · Mar 31, 2022 −$728.45K
Operating Income Q1 2022 · Mar 31, 2021 −$2.63M
Gross Profit Q1 2022 · Mar 31, 2022 −$42.65K
Gross Profit Q1 2022 · Mar 31, 2021 $39.51K
Revenue Q1 2022 · Mar 31, 2022 $80.48K
Revenue Q1 2022 · Mar 31, 2021 $136.37K